[go: up one dir, main page]

PT811008E - Derivados biciclicos de benzodiazepina como antagonistas de vasopressina - Google Patents

Derivados biciclicos de benzodiazepina como antagonistas de vasopressina

Info

Publication number
PT811008E
PT811008E PT96903711T PT96903711T PT811008E PT 811008 E PT811008 E PT 811008E PT 96903711 T PT96903711 T PT 96903711T PT 96903711 T PT96903711 T PT 96903711T PT 811008 E PT811008 E PT 811008E
Authority
PT
Portugal
Prior art keywords
benzodiazepine
vasopressin antagonists
bicyclic derivatives
bicyclic
derivatives
Prior art date
Application number
PT96903711T
Other languages
English (en)
Inventor
Jay Donald Albright
Effren Guillermo Delos Santos
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of PT811008E publication Critical patent/PT811008E/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10Laxatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/10Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • A61P5/12Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH for decreasing, blocking or antagonising the activity of the posterior pituitary hormones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/82Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/84Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Endocrinology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pulmonology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
PT96903711T 1995-01-17 1996-01-16 Derivados biciclicos de benzodiazepina como antagonistas de vasopressina PT811008E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/373,839 US5696112A (en) 1995-01-17 1995-01-17 Fused heterocyclic azepines as vasopressin antagonists

Publications (1)

Publication Number Publication Date
PT811008E true PT811008E (pt) 2004-02-27

Family

ID=23474102

Family Applications (1)

Application Number Title Priority Date Filing Date
PT96903711T PT811008E (pt) 1995-01-17 1996-01-16 Derivados biciclicos de benzodiazepina como antagonistas de vasopressina

Country Status (23)

Country Link
US (2) US5696112A (pt)
EP (1) EP0811008B1 (pt)
JP (1) JPH10512572A (pt)
KR (1) KR19980703098A (pt)
CN (1) CN1177356A (pt)
AR (1) AR010195A1 (pt)
AT (1) ATE251166T1 (pt)
AU (1) AU716008B2 (pt)
BR (1) BR9607153A (pt)
CA (1) CA2210571A1 (pt)
CZ (1) CZ224697A3 (pt)
DE (1) DE69630209T2 (pt)
DK (1) DK0811008T3 (pt)
EA (1) EA001427B1 (pt)
ES (1) ES2207672T3 (pt)
HU (1) HUP9800466A3 (pt)
IL (1) IL116776A (pt)
MX (1) MX9705312A (pt)
NZ (1) NZ302119A (pt)
PT (1) PT811008E (pt)
TW (1) TW342385B (pt)
WO (1) WO1996022294A1 (pt)
ZA (1) ZA96298B (pt)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7338796A (en) * 1995-11-09 1997-05-29 Japan Tobacco Inc. Five-membered fused heterocyclic azepine derivatives and pharmaceutical use thereof
US6297234B1 (en) 1999-02-04 2001-10-02 American Home Products Corporation Arylthiophene vasopressin agonists
US6235900B1 (en) 1999-02-04 2001-05-22 American Home Products Corporation Tricyclic pyridine N-oxides vasopressin agonists
US6437006B1 (en) 1999-09-27 2002-08-20 American Cyanamid Company Pharmaceutical carrier formulation
BR0208824A (pt) 2001-04-12 2004-03-09 Wyeth Corp Composto, métodos de tratamento de distúrbios que são remediados ou aliviados por atividade de agonista de vasopressina em um mamìfero, e de indução de retardamento temporário de urinação em um mamìfero, e, composição farmacêutica
US7022699B2 (en) 2001-04-12 2006-04-04 Wyeth Cyclohexenyl phenyl diazepines vasopressin and oxytocin receptor modulators
US7109193B2 (en) 2001-04-12 2006-09-19 Wyeth Tricyclic diazepines tocolytic oxytocin receptor antagonists
US6977254B2 (en) * 2001-04-12 2005-12-20 Wyeth Hydroxy cyclohexenyl phenyl carboxamides tocolytic oxytocin receptor antagonists
US6900200B2 (en) 2001-04-12 2005-05-31 Wyeth Tricyclic hydroxy carboxamides and derivatives thereof tocolytic oxytocin receptor antagonists
CN1516589A (zh) * 2001-04-12 2004-07-28 用作加压素激动剂的n-联苯羰基-和n-苯基吡啶基羰基取代的二环和三环氮杂�类和二氮杂�类化合物
US7064120B2 (en) * 2001-04-12 2006-06-20 Wyeth Tricyclic pyridyl carboxamides and derivatives thereof tocolytic oxytocin receptor antagonists
US7202239B2 (en) * 2001-04-12 2007-04-10 Wyeth Cyclohexylphenyl carboxamides tocolytic oxytocin receptor antagonists
US7326700B2 (en) * 2001-04-12 2008-02-05 Wyeth Cyclohexenyl phenyl carboxamides tocolytic oxytocin receptor antagonists
SE0102299D0 (sv) 2001-06-26 2001-06-26 Astrazeneca Ab Compounds
SE0102764D0 (sv) 2001-08-17 2001-08-17 Astrazeneca Ab Compounds
EP1632494A1 (en) 2004-08-24 2006-03-08 Ferring B.V. Vasopressin v1a antagonists
JP4651714B2 (ja) 2005-07-09 2011-03-16 アストラゼネカ アクチボラグ 糖尿病の治療においてglk活性化剤として使用するためのヘテロアリールベンズアミド誘導体
BRPI0710479A2 (pt) 2006-01-18 2012-08-14 Hoffmann La Roche composto, processo para sua preparaÇço, composiÇço farmacÊutica, uso de um composto e mÉtodo de tratamento de doenÇa ou desosrdem metabàlica.
EP2403860B1 (en) * 2009-03-04 2015-11-04 IDENIX Pharmaceuticals, Inc. Phosphothiophene and phosphothiazole as hcv polymerase inhibitors
WO2010116176A1 (en) 2009-04-09 2010-10-14 Astrazeneca Ab Pyrazolo [4, 5-e] pyrimidine derivative and its use to treat diabetes and obesity
US10626126B2 (en) 2016-04-08 2020-04-21 Pulmocide Limited Compounds

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA821020B (en) * 1981-02-18 1983-10-26 Thomae Gmbh Dr K Azepine derivatives, process for their preparation and pharmaceutical compositions thereof
US4766108A (en) * 1986-12-04 1988-08-23 Smith Kline Beckman Corporation Tyr-Arg-vasopressin antagonists
US5055448A (en) * 1987-06-25 1991-10-08 Medical College Of Ohio Linear derivatives of arginine vasopressin antagonists
DE69009785T2 (de) * 1989-02-10 1994-11-03 Otsuka Pharma Co Ltd Carbostyrilderivate.
EP0450097B1 (en) * 1989-10-20 1996-04-24 Otsuka Pharmaceutical Co., Ltd. Benzoheterocyclic compounds
US5258510A (en) * 1989-10-20 1993-11-02 Otsuka Pharma Co Ltd Benzoheterocyclic compounds
US5070187A (en) * 1989-11-03 1991-12-03 Trustees Of Boston University Pharmacologically effective antagonists of arginine-vasopressin
TW199153B (pt) * 1990-08-07 1993-02-01 Dtsuka Seiyaku Kk
CA2066104C (en) * 1991-04-19 2003-05-27 Hidenori Ogawa Benzazepine derivatives as vasopressin antagonists
EP0533240A3 (en) * 1991-09-16 1993-09-29 Merck & Co. Inc. Substituted amine derivatives of piperazinylcamphorsulfonyl oxytocin antagonists
DE69223573D1 (de) * 1991-09-16 1998-01-29 Merck & Co Inc Hydantoin und Succinimid-substituierte Spiroindanylcamphorsulfonyl als Oxytocin-Antagonisten
US5204349A (en) * 1991-09-16 1993-04-20 Merck & Co., Inc. Amide-substituted derivatives of spiroindanylcamphorsulfonyl oxytocin antagonists
EP0533242A3 (en) * 1991-09-16 1993-09-15 Merck & Co. Inc. Substituted derivatives of piperazinylcamphorsulfonyl oxytocin antagonists
AU657431B2 (en) * 1992-08-20 1995-03-09 Otsuka Pharmaceutical Co., Ltd. Benzoheterocyclic compounds as oxytocin and vasopressin antagonists
TW270927B (pt) * 1992-10-16 1996-02-21 Otsuka Pharma Co Ltd
WO1994012476A1 (fr) * 1992-11-25 1994-06-09 Yamanouchi Pharmaceutical Co., Ltd. Derive de benzanilide
WO1994014796A1 (fr) * 1992-12-21 1994-07-07 Yamanouchi Pharmaceutical Co., Ltd. Nouveau derive de n-(pyridylcarbonyl)benzazepine et son intermediaire
WO1994020473A1 (fr) * 1993-03-11 1994-09-15 Yamanouchi Pharmaceutical Co., Ltd. Compose avec action antagoniste de la vasopressine
GB9307527D0 (en) * 1993-04-13 1993-06-02 Fujisawa Pharmaceutical Co New venzamide derivatives,processes for the preparation thereof and pharmaceutical composition comprising the same

Also Published As

Publication number Publication date
KR19980703098A (ko) 1998-10-15
TW342385B (en) 1998-10-11
BR9607153A (pt) 1997-11-11
EP0811008A1 (en) 1997-12-10
WO1996022294A1 (en) 1996-07-25
US5696112A (en) 1997-12-09
ZA96298B (en) 1997-07-15
AU4770696A (en) 1996-08-07
HUP9800466A2 (hu) 1998-07-28
CA2210571A1 (en) 1996-07-25
DK0811008T3 (da) 2004-01-26
ES2207672T3 (es) 2004-06-01
NZ302119A (en) 2000-02-28
AU716008B2 (en) 2000-02-17
CN1177356A (zh) 1998-03-25
EA001427B1 (ru) 2001-02-26
MX9705312A (es) 1997-10-31
US5654297A (en) 1997-08-05
IL116776A0 (en) 1996-05-14
IL116776A (en) 2000-10-31
EA199700115A1 (ru) 1997-12-30
HUP9800466A3 (en) 1998-12-28
EP0811008B1 (en) 2003-10-01
DE69630209D1 (de) 2003-11-06
AR010195A1 (es) 2000-06-07
JPH10512572A (ja) 1998-12-02
ATE251166T1 (de) 2003-10-15
DE69630209T2 (de) 2004-08-19
CZ224697A3 (cs) 1998-01-14

Similar Documents

Publication Publication Date Title
PT811008E (pt) Derivados biciclicos de benzodiazepina como antagonistas de vasopressina
BR9607182A (pt) Antagonistas de vasopressina de benzazepina tricíclicos
BR9606977A (pt) Antagonistas de vasopressina de benzazepina triciclica
DK0805813T3 (da) Tricyclic vasopressin antagonists
BR9607186A (pt) Antagonistas de vasopressina de benzazepina triciclica
BR9710087A (pt) Antagonistas de vasopressina de benzazepina tricíclicos
DK0738150T3 (da) Bicykliske fibrinogene antagonister
BR9612126A (pt) Derivados de benzazepina
BR9610823A (pt) Derivados de pirimidina como antagonistas do receptor
BR9707391A (pt) Pirazolpirimidinas como antagonistas de receptor de crf
EP0868178A4 (en) GONADOTROPIN RELEASING HORMON ANTAGONISTS
ATE249465T1 (de) Tricyclische benzodiazepine als vasopressin antagonisten
PT940391E (pt) Derivados de quinolina como antagonistas do receptor de taquicinina nk3
EP0986385A4 (en) GONADORELIN ANTAGONISTS
FI960516L (fi) Substituoituja bifenyylisulfonamidiendoteliiniantagonisteja
PT1036072E (pt) Antagonistas de receptores de trombina
PT854867E (pt) Tetra-hidroquinolinas como antagonistas de nmda
PT746979E (pt) Utilizacao de compostos pirrolo como agentes anti-incrustadores
FI943808A7 (fi) Triatsolopyrimidiinijohdannaisia angiotensiini II:n reseptoreiden vast avaikuttajina
EE9700207A (et) Teraapias kasutatavad bitsüklilised amidiini derivaadid
BR9207071A (pt) 3-Fenilureído-azepin-2-onas e-benzazepin-2-onas úteis como antagonistas de colecistoquinina
BR1100543A (pt) antagonistas bicìclicos de fibrinogênio
HK1003264A (en) Bicyclic benzazepine derivatives as vasopressin antagonists
SI0804438T1 (sl) Triciklicni benzazepinski antagonisti vazopresina